




Searching News Database: matrix metalloproteinase
HSMN NewsFeed - 1 Oct 2012
Study Finds 78% Drop In Surgical Site Infection With AQUACEL(R) Ag SURGICAL Cover Dressing
Study Finds 78% Drop In Surgical Site Infection With AQUACEL(R) Ag SURGICAL Cover Dressing
HSMN NewsFeed - 13 Feb 2012
ConvaTec Introduces AQUACEL(R) EXTRA(TM) Wound Dressings With Hydrofiber(R) Technology in U.S.
ConvaTec Introduces AQUACEL(R) EXTRA(TM) Wound Dressings With Hydrofiber(R) Technology in U.S.
HSMN NewsFeed - 2 Sep 2010
ConvaTec Expands AQUACEL(R) Dressing Product Line With Introduction of New Ribbon Dressing
ConvaTec Expands AQUACEL(R) Dressing Product Line With Introduction of New Ribbon Dressing
HSMN NewsFeed - 31 Mar 2010
ConvaTec Introduces AQUACEL(R) Ag SURGICAL Cover Dressings With Hydrofiber(R) Technology
ConvaTec Introduces AQUACEL(R) Ag SURGICAL Cover Dressings With Hydrofiber(R) Technology
HSMN NewsFeed - 21 Oct 2009
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
HSMN NewsFeed - 23 Mar 2009
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
Medline Introduces MatriStem(TM) Extracellular Matrix That Taps Body's Own Capabilities to Repair Tissue
HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
HSMN NewsFeed - 6 Jun 2007
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
HSMN NewsFeed - 2 May 2007
PTC Therapeutics Announces Promotion of Neil Almstead to Senior Vice President of Chemistry and CMC
PTC Therapeutics Announces Promotion of Neil Almstead to Senior Vice President of Chemistry and CMC
HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
HSMN NewsFeed - 1 Aug 2006
NIH Researchers Find RegeneRx's Drug Candidate Regulates Key Proteins Important in Wound Repair
NIH Researchers Find RegeneRx's Drug Candidate Regulates Key Proteins Important in Wound Repair
HSMN NewsFeed - 3 Apr 2006
ImClone Systems Announces Receipt of $250 Million Milestone Payment from Bristol-Myers Squibb
ImClone Systems Announces Receipt of $250 Million Milestone Payment from Bristol-Myers Squibb
Additional items found! 6

Members Archive contains
6 additional stories matching:
matrix metalloproteinase
(Password required)
matrix metalloproteinase
(Password required)